MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

From Medicineworld.org: Pancreatic Cancer Linked to Insulin Resistance

Cancer main Cancer news Breast cancer  

Pancreatic Cancer Linked to Insulin Resistance


Pancreatic Cancer Linked to Insulin Resistance
A new study led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, shows for the first time that male smokers with the highest insulin levels are twice as likely to develop pancreas cancer as men with the lowest levels. Similarly, men with glucose levels in the range of clinical diabetes were twice as likely to develop the cancer as men with normal glucose levels. This study examined data from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study* of 29,000 male smokers in Finland and appears in the December 14, 2005, issue of the Journal of the American Medical Association.

Study investigators drew blood from enrollees when they joined the ATBC Study in the mid-1980s. This allowed the scientists to determine participants' overnight fasting insulin and glucose levels a number of years ahead of when they might be diagnosed with cancer. Over the course of 17 years, 169 men in the study developed pancreas cancer.

Study results show a two-fold increase in risk of pancreas cancer in the quartile of men with the highest fasting serum insulin levels (greater than 6.1 microinternational units per milliliter) compared to those in the lowest quartile (less than 2.75 microinternational units per milliliter). Increasing concentrations of glucose, insulin, and insulin resistance were also associated with pancreas cancer. Moreover, the risk for pancreas cancer increased with longer follow-up time.

"Some men were in the highest quartile of insulin or had abnormal glucose levels more than a decade before the cancer appeared," noted lead researcher Rachael Stolzenberg-Solomon, Ph.D., of NCI's Division of Cancer Epidemiology and Genetics. "It is important to note, however, that this study was only done in male smokers and that any assumptions about risk in the general population or whether one can determine their own pancreas cancer risk specifically based on insulin levels is premature."

In their analysis, the scientists excluded men who developed pancreas cancer within five years of having their blood drawn. This exclusion reduced the likelihood of including men whose elevated insulin levels may have been caused by undetected pancreatic tumors.

Smoking, aging, and perhaps obesity are the only known risk factors for pancreas cancer, one of the most deadly cancers. Only 4 percent of people survive five years after being diagnosed with the disease. There are few therapys, and the cancer is frequently discovered only after a tumor has spread beyond the pancreas. It is estimated that 31,800 people in the United States -- including 15,820 men -- will die from pancreas cancer in 2005.

Cancers of the colon, breast, liver, and pancreas are among those that tend to occur with type-2 diabetes among adults. Clinical diabetes is defined as glucose levels greater than or equal to 126 milligrams per deciliter. But epidemiologic studies on the subject are inconsistent, and scientists are only beginning to understand how the diseases might be related and how best to treat patients diagnosed with both type-2 diabetes and cancer. It is possible that type-2 diabetes could be related to pancreas cancer through the growth regulatory effects of insulin. Few studies have been done specifically to understand how the diseases are related. Instead, scientists have focused largely on identifying cancers that occur with diabetes (or pre-diabetic states) and explaining why this happens.

This study supports the longstanding hypothesis that insulin is a growth promoter for pancreas cancer. "This study of insulin levels gives us another important clue about the various influences that are probably important in the risk of developing pancreas cancer, and possibly other cancers, especially in smokers," said Demetrius Albanes, M.D., senior researcher for the NCI team.

The findings must be replicated in other groups, including women and non-smokers, but the results are consistent with other recent studies.

An earlier study in JAMA*** found that diabetes and elevated fasting glucose levels were independent risk factors for several major cancers, including pancreas cancer, among 1.3 million Koreans. The participants were far leaner than those in studies involving Westerners. Noting that obesity was not a factor in the results, the scientists suggested that elevated insulin levels may account for the increased cancer risk.

In May 2005, an analysis of 36 studies involving diabetes and pancreas cancer found a modest causal association between type-2 diabetes and the cancer. After obesity and smoking, diabetes may be the third modifiable risk factor for pancreas cancer, the scientists concluded in the British Journal of Cancer.


Did you know?
A new study led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, shows for the first time that male smokers with the highest insulin levels are twice as likely to develop pancreas cancer as men with the lowest levels. Similarly, men with glucose levels in the range of clinical diabetes were twice as likely to develop the cancer as men with normal glucose levels. This study examined data from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study* of 29,000 male smokers in Finland and appears in the December 14, 2005, issue of the Journal of the American Medical Association.

Medicineworld.org: Pancreatic Cancer Linked to Insulin Resistance

Cancer terms| History of cancer| Imaging techniques| Cancer Main| Bladder cancer news| Cervix cancer news| Colon cancer news| Esophageal cancer news| Gastric cancer news| Health news| Lung cancer news| Breast cancer news| Ovarian cancer news| Cancer news| Pancreatic cancer news| Prostate cancer news| Endometrial cancer news| General info| What is cancer?| Cancer causes| Is cancer hereditary?| Types of cancer| Cancer statistics| Breast cancer main| Breast cancer symptoms| Colon cancer main| Anal cancer| Bladder cancer main| Lung cancer general| Lung cancer main| Non small cell| Small cell| Ovarian cancer main| Treatment of ovarian cancer| Prostate cancer main| Updates in oncology| Acute myeloid leukemia|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.